Successful treatment of refractory recurrent vaginal candidiasis with cetirizine plus fluconazole

Journal of Lower Genital Tract Disease

Volumn 9, Issue 3, 2005, Pages 167-170

  Neves, Nilma A ^a   Carvalho, Lucas P ^a   Lopes, Antônio Carlos V ^a   Cruz, Álvaro ^a   Carvalho, Edgar M ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Allergy; Antihistamine; Fluconazole; Recurrent vaginal candidiasis; Skin prick test

Indexed keywords

ALLERGEN; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; CETIRIZINE; CLOTRIMAZOLE; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE;

ALLERGY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CLINICAL ARTICLE; DRUG EFFICACY; FAMILY HISTORY; FEMALE; FOLLOW UP; FUNGUS CULTURE; HUMAN; PRICK TEST; PRURITUS; RECURRENT INFECTION; REMISSION; SKIN TEST; TREATMENT OUTCOME; VAGINA CANDIDIASIS; VAGINITIS;

ADULT; ANTI-ALLERGIC AGENTS; ANTIFUNGAL AGENTS; CANDIDIASIS, VULVOVAGINAL; CETIRIZINE; FEMALE; FLUCONAZOLE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; HYPERSENSITIVITY; RECURRENCE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 23244446980     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.LGT.0000171664.63976.FB     Document Type: Article

References (32)

1. Sobel JD. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 1985;152: 924-35.
2. Hurley R. Recurrent Candida infection. Clin Obstet Gynecol 1981;8:209-14.
3. Sobel JD. Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann N Y Acad Sci 1988;544:547-57.
4. Fleury FJ. Adult vaginitis. Clin Obstet Gynecol 1981; 24:407-38.
5. Morton RS, Rashid S. Candidal vaginitis: natural history, predisposing factors and prevention. Proc R Soc Med 1977;70:3-12.
6. Spinillo A, Pizzoli G, Colonna L, Nicola S, De Seta F, Guaschino S. Epidemiologic characteristics of women with idiopathic recurrent vulvovaginal candidiasis. Obstet Gynecol 1993;81:721-7.
7. Sobel JD. Vaginitis. N Engl J Med 1997;337:1896-903.
8. MacNeill C, Weisz J, Carey JC. Clinical resistance of recurrent Candida albicans vulvovaginitis fluconazole in the presence and absence of in vitro resistance. J Reprod Med 2003;48:63-8.
9. Fong IW, Bannatyne RM, Wong P. Lack of in vitro resistance of Candida albicans to ketoconazole, itraconazole and clotrimazole in women treated for recurrent vaginal candidiasis. Genitourin Med 1993;69:44-6.
10. Fidel PL, Sobel JD. Immunopathogenesis of recurrent vulvovaginal candidiasis. Clin Microbiol Rev 1996;9:335-48.
11. Syverson RE, Buckley H, Gibian J, Ryan GM. Cellular and humoral immune status in women with chronic Candida vaginitis. Am J Obstet Gynecol 1979;134:624-7.
12. Fong IW, McCleary P, Read S. Cellular immunity of patients with recurrent or refractory vulvovaginal moniliasis. Am J Obstet Gynecol 1992;166:887-90.
13. Corrigan EM, Clancy RL, Dunkley ML, Eyers FM, Beagley KW. Cellular immunity in recurrent vulvovaginal candidiasis. Clin Exp Immunol 1998;111:574-8.
14. Witkin SS. Inhibition of Candida-induced lymphocyte proliferation by antibody to Candida albicans. Obstet Gynecol 1986;68:696-9.
15. Lilic D, Cant AJ, Abiunun M, Calvert JE, Spickett GP. Chronic mucocutaneous candidiasis. Clin Exp Immunol 1996; 105:205-12.
16. Kirkpatrick C. Chronic mucocutaneous candidiasis. Eur J Clin Microbiol Infect Dis 1989;8:448-56.
17. Witkin SS, Jeremias J, Ledger WJ. Vaginal eosinophilis and IgE antibodies to Candida albicans in women with recurrent vaginitis. J Med Vet Mycol 1989;27:57-8.
18. Witkin SS, Jeremias J, Ledger WJ. A localized vaginal allergic response in women with recurrent vaginitis. J Allergy Clin Immunol 1988;81:412-6.
19. Beasley R. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis and atopic eczema: ISAAC. Lancet 1998;351:1225-32.
20. Middleton E Jr, Reed CE, Ellis EF, Adkinson Jr NF, Yunginger JW, Busse WW, eds. Allergy Principles and Practice, 5th ed. Mosby; 1998:430-7.
21. Sobel JD. Recurrent vulvovaginal candidiasis: a prospective study of the efficacy of maintenance ketoconazole therapy. N Engl J Med 1986;315:1455-8.
22. Van Heusden AM, Merkus JM. Chronic recurrent vaginal candidosis: easy to treat, difficult to cure. Results of intermittent treatment with a new oral antifungant. Eur J Obstet Gynecol and Reprod Biol 1990;35:75-83.
23. Sobel JD. Treatment of recurrent vulvovaginal candidiasis with maintenance fluconazole. Int J Gynaecol Obstet 1992;37:17-34.
24. Sobel JD. Recurrent Candida vaginitis: a rational approach to therapy. Drug Ther 1982;12:41-55.
25. Dellenbach P. Penetration of fluconazole into vaginal tissues and secretions. In: Richardson RG, ed. Fluconazole and its Role in Vaginal Candidiasis. Royal Society of Medicine Services; 1989:19-24.
26. Houang ET, Chappatte O, Byrne D, Macrae PV, Thorpe JE. Fluconazole levels in plasma and vaginal secretion of patients after a 150 mg single oral dose and rate of eradication of infection in vaginal candidiasis. Antimicrob Agents Chemother 1990;34:909.
27. Sobel JD. Management of patients with recurrent vulvovaginal candidiasis. Drugs 2003;63(11):1059-66.
28. Carvalho LP, Bacellar O, Neves N, Jesus A, Carvalho E. Downregulation of IFN-gamma production in patients with recurrent vaginal candidiasis. J Allergy Clin Immunol 2002; 109:102-5.
29. Witkin SS. Immunologic influencing susceptibility to recurrent candidal vaginitis. Clin Obstet Gynecol 1991;34:662-8.
30. Moraes PSA. Recurrent vaginal candidiasis and allergic rhinitis: a common association. Ann Allergy Asthma Immunol 1998;81:165-9.
31. Cenci E, Mencacci A, Del Sero G, Bistoni F, Romani L. Induction of protective Th1 response to Candida albicans by antifungal therapy alone or in combination with an interleukin-4 antagonist. J Infectious Disease 1997;176:217-26.
32. Rigg D, Miller MM, Metzger J. Recurrent allergic vulvovaginitis: treatment with Candida albicans allergen immunotherapy. Am J Obstet Gynecol 1990;162:332-36.